Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.84 | N/A |
| PEG Ratio (TTM) | 3.83 | N/A |
| P/S Ratio (TTM) | 1.82 | N/A |
| P/B Ratio (TTM) | 13.23 | N/A |
| P/FCF Ratio (TTM) | 9.91 | N/A |
| Price to 5YR AVG Earnings Ratio | 28.72 | N/A |
| Price to 5YR AVG FCF Ratio | 15.24 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 15.16% | N/A |
| ROE (TTM) | 67.58% | N/A |
| Net Profit Margin (TTM) | 9.72% | N/A |
| ROIC 5YR AVG | 26.98% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 6.51% | 30.67% | 23.06% |
| Revenue | 0.78% | -2.49% | -0.42% |
| Net Income | 6.33% | 31.58% | 22.89% |
| Cash Flow | 129.82% | 285.36% | 222.42% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.50 | N/A |
| Quick Ratio (TTM) | 1.42 | N/A |
| D/E Ratio (TTM) | 2.15 | N/A |
| Interest Coverage (TTM) | 7.78 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 5.01 | N/A |
| LTL to 5YR AVG FCF | 2.60 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.17% | N/A |